Since the first case recorded in the end of 2019, the virus SARS-CоV-2 and the related lung disease COVID-19 have spread over the world and became a threat for public health. The drugs used for treatment of this disease (azithromycin and hydroxychloroquine) can prolong the QT interval on the electrocardiogram to increase the risk of pirouette tachycardia and sudden cardiac death. This article presents a review of potential risks related with the drug treatment of COVID-19 and provides recommendations for management of patients during the pandemic.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.18087/cardio.2020.7.n1201 | DOI Listing |
Publication Analysis
Top Keywords
[qt interval
4
interval patients
4
patients covid-19]
4
covid-19] case
4
case recorded
4
recorded 2019
4
2019 virus
4
virus sars-cоv-2
4
sars-cоv-2 lung
4
lung disease
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!